Genix Pharmaceuticals Corporation
GENX.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.20K | 8.20K | 7.40K | 6.90K | 6.90K |
| Total Receivables | 4.90K | 4.20K | 3.60K | 2.70K | 2.20K |
| Inventory | -- | -- | 115.80K | 116.60K | 120.40K |
| Prepaid Expenses | 27.50K | 15.40K | 36.70K | 48.40K | 49.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 34.50K | 27.80K | 163.40K | 174.60K | 178.70K |
|
|
|||||
| Total Current Assets | 34.50K | 27.80K | 163.40K | 174.60K | 178.70K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.50K | 4.90K | 5.10K | 5.30K | 5.70K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 39.00K | 32.70K | 168.50K | 180.00K | 184.40K |
|
|
|||||
| Total Accounts Payable | 118.90K | 107.30K | 191.00K | 204.30K | 209.90K |
| Total Accrued Expenses | 9.00K | 14.40K | 10.90K | 7.30K | 11.20K |
| Short-term Debt | 627.60K | 585.30K | 535.20K | 480.90K | 430.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 175.10K | 174.80K | 419.30K | 420.60K | 427.50K |
| Total Other Current Liabilities | 175.10K | 174.80K | 419.30K | 420.60K | 427.50K |
| Total Current Liabilities | 930.70K | 881.80K | 1.16M | 1.11M | 1.08M |
|
|
|||||
| Total Current Liabilities | 930.70K | 881.80K | 1.16M | 1.11M | 1.08M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 627.60K | 585.30K | 535.20K | 480.90K | 430.10K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 930.70K | 881.80K | 1.16M | 1.11M | 1.08M |
|
|
|||||
| Common Stock & APIC | 6.70M | 6.96M | 7.02M | 7.06M | 7.25M |
| Retained Earnings | -8.51M | -8.76M | -8.95M | -8.93M | -9.11M |
| Treasury Stock & Other | 912.00K | 947.20K | 935.80K | 940.50K | 966.10K |
| Total Common Equity | -891.60K | -849.10K | -987.80K | -933.00K | -894.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -891.60K | -849.10K | -987.80K | -933.00K | -894.30K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -891.60K | -849.10K | -987.80K | -933.00K | -894.30K |
|
|
|||||